Literature DB >> 3293806

Polyalkylcyanoacrylates as colloidal drug carriers.

P Couvreur1.   

Abstract

A considerable amount of energy has been spent in creating new colloidal drug delivery systems that are acceptable for general systemic use. Among these new systems, nanoparticles made with biodegradable polymers are gaining more and more interest. The aim of this paper is to describe the preparation and characterization of these nanoparticles and their in vivo behavior and to show the possibilities of using them in various fields of human medicine. The interaction of polyalkylcyanoacrylate nanoparticles with cells in culture is also discussed, as well as the possibility of improving the specificity of the carrier by coating it with monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293806

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  13 in total

1.  Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.

Authors:  Bénédicte Pradines; Christian Bories; Christine Vauthier; Gilles Ponchel; Philippe M Loiseau; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

2.  Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant.

Authors:  R H Müller; D Rühl; S Runge; K Schulze-Forster; W Mehnert
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

3.  Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles.

Authors:  S K Das; I G Tucker; D J Hill; N Ganguly
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 4.  Liposomes and nanoparticles in the treatment of intracellular bacterial infections.

Authors:  P Couvreur; E Fattal; A Andremont
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

5.  Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production.

Authors:  R Gaspar; V Préat; F R Opperdoes; M Roland
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

6.  Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Authors:  J Kattan; J P Droz; P Couvreur; J P Marino; A Boutan-Laroze; P Rougier; P Brault; H Vranckx; J M Grognet; X Morge
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

7.  Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles.

Authors:  F Lescure; C Seguin; P Breton; P Bourrinet; D Roy; P Couvreur
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

8.  Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.

Authors:  H Pinto-Alphandary; O Balland; M Laurent; A Andremont; F Puisieux; P Couvreur
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

9.  Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.

Authors:  E Fattal; M Youssef; P Couvreur; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.

Authors:  Consolación Melguizo; Laura Cabeza; Jose Prados; Raúl Ortiz; Octavio Caba; Ana R Rama; Ángel V Delgado; José L Arias
Journal:  Drug Des Devel Ther       Date:  2015-12-14       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.